Effectiveness of premedication protocol using intravenous fentanyl to reduce pain associated with femoral artery closure device placement. Issue 2 (February 2019)

• Record Type: Journal Article
• Authors: Qureshi, A.I.; Saleem, M.A.; Naseem, N.; Wallery, S.S.
• Is Part Of: Clinical radiology. Volume 74:Issue 2(2019)
• Page Start: 166.e9
• Page End: 166.e13
• Publication Date: 2019-02
• Subjects: Medical radiology -- Periodicals; Radiotherapy -- Periodicals; Radiotherapy -- Periodicals; Radiology -- Periodicals; Societies, Medical -- Periodicals; Medical radiology; Radiotherapy; Electronic journals; Periodicals; 616.0757
• DOI: 10.1016/j.crad.2018.10.016
• Languages: English
• ISSNs: 0009-9260

Abstract

Abstract : Aim: To test the effectiveness of a premedication protocol using intravenous bolus of 100 μg fentanyl to reduce pain associated with femoral artery closure device placement for neuro-endovascular procedures. Materials and methods: The severity of pain associated with femoral artery closure device placement was analysed using a numerical rating scale score ranging from 0 (no pain) to 10 (most severe pain) in two cohorts of consecutive adult patients ( n =118), those who were ( n =64) or were not ( n =54) treated with premedication protocol. The primary endpoints were the proportion of patients with excellent (score ≤1) and failed pain control (score ≥8). Stepwise logistic regression analysis was performed to identify the effect of premedication on pain control after adjustment for potential confounders. Results: The median numerical pain rating score at femoral artery closure device placement was significantly lower in patients treated with premedication protocol compared with those who underwent closure without premedication (1 versus 5, p <0.001). There was a significantly higher rate of excellent (56.2% versus 14.8%, p <0.001) and good (68.7% versus 31.2%, p <0.001) pain control at closure device placement among patients treated with premedication protocol. None of the patients treated with premedication protocol reported failed pain control compared with 33.4% of those who underwent closure device placement without premedication. In the multivariate analysis, treatment with the premedication protocol was significantly associated with an increased rate of excellent pain control (odds ratio 2.3; 95% confidence interval 1.9–3.1). Conclusion: Premedication with intravenous fentanyl injection prior to femoral artery closure device placement can reduce the intensity of pain associated with closure. Highlights: We identified benefit of premedication with IV Fentanyl to reduce pain during femoral closure device placement. All the patients treated with premedication protocol reported fair pain control compared with those who were not premedicated. Treatment with premedication protocol was significantly associated with excellent pain control at closure device placement.